Jason Wild is the President and Chief Investment Officer of JW Asset Management, LLC. The firm has a strong history of finding opportunities within the healthcare sector, investing in both private and public companies. Since inception in 1999, JW Partners, LP has gained 27.31% annually net of all fees and expenses compared to 6.27% for the S&P 500 during the same period. (Ending 8/31/18) Mr. Wild is the Chairman of the Board at Arbor Pharmaceuticals, a private pharmaceutical company based in Atlanta, Georgia where JW Asset Management along with KKR are the company’s two largest investors. JW has been an active investor in the Cannabis sector since 2014, investing in many of the sector leaders, including Canopy Growth, Cronos Group and TerrAscend Corp., where he is the Chairman of the Board.